Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Mar 1, 2004; 10(5): 654-659
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.654
Table 1 Cell growth-inhibition of SMMC7721 cells
GroupsOD (mean ± SD)Cell growth-inhibition rate (%)
PBS1.25 ± 0.200
TRAIL0.11 ± 0.02ac91.2
Bax0.65 ± 0.13a48.0
LacZ0.89 ± 0.0428.8
Table 2 Cell growth-inhibition of NHFB cells
GroupsOD (mean ± SD)Cell growth-inhibition rate (%)
PBS0.66 ± 0.020
TRAIL0.62 ± 0.02c6.1
Bax0.36 ± 0.02a45.5
LacZ0.61 ± 0.037.6
Table 3 Percentage of apoptotic SMMC7721 cells
GroupsPercentage of apoptotic cells (%, mean ± SD)
TRAIL29.07 ± 4.96ace
Bax12.53 ± 1.23ae
LacZ6.58 ±0.49ac
PBS2.94 ± 0.63ce
Table 4 Bystander effects of TRAIL on SMMC7721 cells
Percentage ofSMMC7721/TRAIL (%)OD (mean ± SD)Cell growth-inhibitionrate (%)
00.693 ± 0.0280
50.583 ± 0.03615.9
250.228 ± 0.01467.0
500.137 ± 0.01980.2
750.094 ± 0.00986.4
1000.084 ± 0.01087.7
Table 5 Percentage of apoptotic SMMC7721 cells
GroupsOD (mean ± SD)Cell growth-inhibition rate (%)
PBS0.846 ± 0.0160
Cultured medium0.794 ± 0.0274.0
TRAIL0.108 ± 0.010a87.5